Modified Release

Controlled release (CR) oral drug delivery systems are employed to improve patient compliance and therapeutic outcomes. Modified release (MR) dosage forms can be utilized to reduce the number of times the patient has to administer medication over the course of the day. They can also be utilized to prolong the time in which the systemic blood concentration remains within the therapeutic window, while avoiding potential adverse events from spikes in drug concentration.

Enabling Technologies

We offer a portfolio of functional polymeric excipients, which are utilized to formulate various modified release dosage forms like hydrophilic matrix tablets, inert matrices, barrier-coated multiparticulates and osmotic pump technology. Our strength is our commitment to quality and consistency. Our products are fully certified for pharmaceutical use, come in a wide variety of molecular weights and offer innovations for all kinds of tablet designs

Get Started

DuPont cares about your privacy. Your personal information (name, email, phone number and other contact data) will be stored in chosen customer systems primarily hosted in the United States. This information will be used by DuPont, its affiliates, partners, and selected third parties in other countries to provide you with the product or service information requested. To learn more, please visit www.privacy.dupont.com. By providing your personal information, you agree to the terms and conditions of this Privacy Statement.